Article: NMNAT1 Protects Injured Axons by Preventing SARM1-Induced NAD+ Loss After Injury: Preclinical Findings

PrevNext
Neurological Health Neuropathy Preclinical

NMNAT1 Protects Injured Axons by Preventing SARM1-Induced NAD+ Loss After Injury: Preclinical Findings

Synopsis

Overexpression of the NAD+ biosynthesis enzyme NMNAT1 helps protect injured axons. Although it's believed that higher NAD+ levels or lower NMN levels are important for this protection, the exact mechanism was unclear. By analyzing NAD+ metabolites in healthy and injured mouse nerve cells, researchers found that NMNAT1 does not increase NAD+ production but instead blocks the injury-triggered, SARM1-dependent consumption of NAD+ that causes axon degeneration.

Journal

eLife

Share

Read more

Cellular Health

Quantification of Nicotinamide Riboside, Nicotinamide Mononucleotide, and NAD+ in Human and Donkey Milk: Preclinical Findings

Synopsis Nicotinamide riboside (NR)—the newest identified form of vitamin B3—and its phosphorylated derivative nicotinamide mononucleotide (NMN) are powerful precursors that increase intracellular...

Read more
Cellular Health

Interaction Between Renalase and Molecules to Regulate Cellular Energy: Preclinical Findings

Synopsis Renalase is an enzyme that helps convert unusual forms of NADH and NADPH—called 2- and 6-isomers—back into their normal active forms, NAD+ and NADP+. These unusual forms can block other i...

Read more